[#item_full_content] Vivera Pharmaceuticals Inc., its CEO, and another company must disgorge about $2.1 million, a federal court ruled in an SEC enforcement suit alleging securities fraud over cannabis-derived products. Read More
[#item_full_content] Vivera Pharmaceuticals Inc., its CEO, and another company must disgorge about $2.1 million, a federal court ruled in an SEC enforcement suit alleging securities fraud over cannabis-derived products. Read More